Clinical Trials Arena
60 Degrees pauses Phase IIB Covid-19 trial for tafenoquine
The company plans to refile the IND after assessing the feasibility of US FDA-suggested trial modifications.
The company plans to refile the IND after assessing the feasibility of US FDA-suggested trial modifications.